戻る
EyePoint Inc (EYPT)価格
EYPT 株価推移チャート
EYPT 収入
EyePoint Inc
$15.08
-4.79%
$-0.75
終値： Jan 16, 16:00:00 GMT-5
$15
-0.53%
$-0.08
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$15.84
始値
$15.95
当日レンジ
$15 - $16.18
52週レンジ
$3.91 - $19.11
取引高
869.1K
平均取引高
1.2M
1株当たり利益(TTM)
-2.99
配当利回り
--
時価総額
$1.2B
EYPTとは何ですか？
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. The company is headquartered in Watertown, Massachusetts and currently employs 165 full-time employees. The company went IPO on 2005-01-27. The firm is focused on developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The Company’s lead product candidate, DURAVYU, is an investigational-sustained delivery treatment for anti-vascular endothelial growth factor (anti-VEGF) mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E. DURAVYU is in Phase III pivotal trials for wet age-related macular degeneration. Additional pipeline programs include EYP-2301, a promising TIE-2 agonist, razuprotafib, formulated in Durasert E to potentially improve outcomes in serious retinal diseases. DURAVYU is also being advanced for the treatment of diabetic macular edema (DME) with the first patient dosing in Phase III trials.